Reporting owner · CIK 0001874147

Goldshleger Ilya

Visual SEC Form 4 history across 1 companies, 4 transactions and 2 filings.

COOChief Operating OfficerRxSight, Inc.
Open-market mix
Filings2Form 4 records
Buying$00 purchases
Selling$14.2K1 sales
Net value−$14.2KBuys minus sells
Companies13 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 25Aug 261Sep 26

Net value flow

Buys minus sells

Feb 25
$0
Aug 26
$0
Sep 26
−$14.2K

Transaction texture

Ownership and ticket size

Average P/S size$14.2K
Median P/S size$14.2K
Direct4
Indirect0
Sep 02, 2026sale

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at RxSight, Inc. on Sep 02, 2026 valued at $14,205.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
RXSTGoldshleger Ilya
COO
exercise5.37k$0M09/0308/31
RXSTGoldshleger Ilya
COO
sale2.04k-$1.42MS09/0309/02
RXSTGoldshleger Ilya
COO
exercise5.37kM09/0308/31
RXSTGoldshleger Ilya
SR
grant125k$0A02/28/202502/27/2025

Goldshleger Ilya Insider Activity FAQ

SEC Form 4 context

Who is Goldshleger Ilya?

Goldshleger Ilya is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001874147.

Which companies has Goldshleger Ilya reported transactions for?

RxSight, Inc.

When was Goldshleger Ilya's latest insider buy?

No open-market insider purchase is available for this period.

When was Goldshleger Ilya's latest insider sale?

sale at RxSight, Inc. on Sep 02, 2026 valued at $14,205.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.